Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting.
Saved in:
| Title: | Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting. |
|---|---|
| Authors: | Bergenstal RM (AUTHOR), Garrison LP (AUTHOR), Miller LA (AUTHOR), Hou L (AUTHOR), Blickensderfer A (AUTHOR), Zagar A (AUTHOR), Stanley S (AUTHOR), Bhargava A (AUTHOR), Wade R (AUTHOR), Herman WH (AUTHOR) |
| Source: | Current Medical Research & Opinion. 2011 Dec, Vol. 27 Issue 12, p2335-2342. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
